Literature DB >> 7094277

Thrombolysis in acute myocardial infarction using intracoronary streptokinase: assessment by thallium-201 scintigraphy.

G Schuler, F Schwarz, M Hofmann, H Mehmel, J Manthey, W Mäurer, B Rauch, H J Herrmann, W Kübler.   

Abstract

Twenty-one patients with acute myocardial infarction, admitted to the hospital within 4 hours after the onset of symptoms, were studied by seven-pinhole thallium-201 scintigraphy before and 1 hour and 24 hours after intracoronary fibrinolysis using streptokinase. The size of the thallium-201 perfusion defect was assessed from myocardial cross sections reconstructed from the original seven-pinhole data and expressed as a fraction of left ventricular circumference. Recanalization was achieved in 16 patients within 3.9 +/- 1.6 hours after onset of symptoms (group A). In these patients, the size of the perfusion defect had decreased from 36 +/- 17% to 19% +/- 15% (p less than 0.001) at 24 hours. No significant change was detected by redistribution at 1 hour after the intervention. In five patients, intracoronary fibrinolysis was unsuccessful, and the vessel remained occluded (group B). The thallium-201 perfusion defect affected 40 +/- 15% of the left ventricular circumference before the intervention; it remained virtually unchanged at 1 hour (37 +/- 16%) and at 24 hours (41 +/- 15%) after fibrinolysis. The perfusion defect was most reduced in patients with extensive collaterals supplying the ischemic area or with subtotal occlusion of the affected coronary artery. We conclude that successful intracoronary fibrinolysis may reduce the size of the thallium-201 perfusion defect in many patients with acute myocardial infarction. One important factor in the final result may be the presence of residual coronary flow supplied by extensive collaterals or by subtotal occlusion of the affected coronary artery when reperfusion is achieved around 4 hours after the onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094277     DOI: 10.1161/01.cir.66.3.658

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Changes in left ventricular regional asynchrony after intracoronary thrombolysis in patients with impending myocardial infarction.

Authors:  D Gibson; H Mehmel; F Schwarz; K Li; W Kübler
Journal:  Br Heart J       Date:  1986-08

3.  Acute coronary occlusion and reperfusion. Reliability of angiographic classification and grading.

Authors:  S G Sorensen; R A Hackworthy; P G Fitzpatrick; W H Barry; R L Menlove; J L Anderson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Urokinase perfusion for axillary-subclavian vein thrombosis.

Authors:  E I Fankuchen; R A Neff; R A Collins; G J Todd; E C Martin
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

6.  Streptokinase, urokinase, and tissue plasminogen activator: pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis.

Authors:  A S Maizel; J J Bookstein
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

7.  Intracoronary thrombolysis in evolving myocardial infarction. Sequential angiographic analysis of left ventricular performance.

Authors:  A Cribier; J Berland; O Champoud; N Moore; P Behar; B Letac
Journal:  Br Heart J       Date:  1983-11

Review 8.  What is established in thrombolytic therapy of acute myocardial infarction? Pharmacological approaches.

Authors:  W Kübler; C Bode; A Schömig; G Schuler; F Schwarz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

9.  Improved detection of myocardial infarction by emission computed tomography with thallium-201. Relation to infarct size.

Authors:  S Tamaki; H Kambara; K Kadota; Y Suzuki; R Nohara; C Kawai; N Tamaki; K Torizuka
Journal:  Br Heart J       Date:  1984-12

Review 10.  Coronary thrombolysis for evolving myocardial infarction.

Authors:  J F Spann; S Sherry
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.